These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8752367)

  • 1. The HIV experience in Florida.
    Nelson RP
    J Fla Med Assoc; 1996; 83(6):401-5. PubMed ID: 8752367
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of HIV infections and prevention of opportunistic infections].
    Raguin G; Véron M
    Rev Infirm; 1994 Feb; (3):18-23. PubMed ID: 7652374
    [No Abstract]   [Full Text] [Related]  

  • 3. Children of the epidemic.
    Vazquez E
    Posit Aware; 1996; 7(5):35-6. PubMed ID: 11363788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in HIV/AIDS therapy.
    Johnson SC; Gerber JG
    Adv Intern Med; 2000; 45():1-40. PubMed ID: 10635044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV management update.
    Hamada OL
    Am Fam Physician; 1997 Dec; 56(9):2186, 2188. PubMed ID: 9402807
    [No Abstract]   [Full Text] [Related]  

  • 6. A killer mimotope with therapeutic activity against AIDS-related opportunistic micro-organisms inhibits ex-vivo HIV-1 replication.
    Casoli C; Pilotti E; Perno CF; Balestra E; Polverini E; Cassone A; Conti S; Magliani W; Polonelli L
    AIDS; 2006 Apr; 20(7):975-80. PubMed ID: 16603848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. General strategies, not rigid rules. Project Inform.
    Posit Aware; 1996; 7(6):23-5. PubMed ID: 11363976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [HIV infection].
    Pasquet A; Yazdanpanah Y
    Rev Prat; 2012 Feb; 62(2):255-62. PubMed ID: 22408879
    [No Abstract]   [Full Text] [Related]  

  • 9. Significant inhibitory effects of Hybridon's antisense compound on various HIV-1 replication steps in in vitro tests.
    AIDS Patient Care STDS; 1996 Dec; 10(6):375-6. PubMed ID: 11361558
    [No Abstract]   [Full Text] [Related]  

  • 10. [A changed pattern of opportunistic infections and malignancies in HIV-seropositive patients after the introduction of intensive anti-HIV-combination therapy].
    Borleffs JC; Schneider MM; Hoepelman IM
    Ned Tijdschr Geneeskd; 1998 Oct; 142(44):2395-9. PubMed ID: 9864534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradigms, platitudes, opportunists.
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1995 Nov; 1(10):16-24, 26-9 contd. PubMed ID: 11362971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early antiretroviral combination therapy--standard today and tomorrow].
    Dtsch Med Wochenschr; 1997 Mar; 122(11 Suppl):1-4. PubMed ID: 9102288
    [No Abstract]   [Full Text] [Related]  

  • 13. [AIDS. Therapeutic approaches in the control of HIV infection].
    Müller WE; Schröder HC
    Med Monatsschr Pharm; 1990 May; 13(5):141-6. PubMed ID: 2192245
    [No Abstract]   [Full Text] [Related]  

  • 14. ICAAC news briefs.
    McGuire S
    Posit Aware; 1996; 7(1):12. PubMed ID: 11363115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Viruses and antiviral drug resistance].
    Hovi T; Järvinen A; Pyhälä R; Ristola M; Salminen M
    Duodecim; 2002; 118(9):911-8. PubMed ID: 12238169
    [No Abstract]   [Full Text] [Related]  

  • 16. [HIV infection: future perspective for a so-called fatal disease?].
    von Overbeck J; Iten A
    Schweiz Med Wochenschr; 1997 Mar; 127(13):521-7. PubMed ID: 9190663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Withdrawal of fluconazole suppressive therapy for thrush in patients responding to combination antiviral therapy including protease inhibitors.
    Gripshover BM; Valdez H; Salata RA; Lederman MM
    AIDS; 1998 Dec; 12(18):2513-4. PubMed ID: 9875599
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pathogenesis of HIV infection. Therapeutic implications].
    Perrin L
    Rev Med Suisse Romande; 1996 May; 116(5):367-70. PubMed ID: 8693273
    [No Abstract]   [Full Text] [Related]  

  • 19. Virological and immunological impact of tuberculosis on human immunodeficiency virus type 1 disease.
    Toossi Z
    J Infect Dis; 2003 Oct; 188(8):1146-55. PubMed ID: 14551885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gulliver's travels in HIVland.
    Weiss RA
    Nature; 2001 Apr; 410(6831):963-7. PubMed ID: 11309625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.